Related Experiment Video
Updated: May 31, 2026

Treatment of Ejaculatory Duct Obstruction by Seminal Vesiculoscopy Assisted Flow Modification
Published on: December 8, 2023
[Endoscopic treatment of vesicoureteral reflux in children]
1U.M.E Carol Davila, Clinica de Chirurgie Pediatrică, Spitalul Clinic de Urgenţă pentru Copii M.S. Curie, Bucureşti.
Insights
Endoscopic subureteral injection effectively treats vesicoureteral reflux (VUR) in children, achieving high success rates with minimal complications. This minimally invasive approach offers a safe and efficient alternative for managing VUR across all grades.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
- Urologic Oncology
Context:
- Vesicoureteral reflux (VUR) is a common condition in children with varying management approaches.
- Consensus guidelines exist, but endoscopic treatment offers an efficient alternative.
- This study evaluates endoscopic subureteral injection for VUR management.
Purpose:
- To assess the efficacy and safety of endoscopic subureteral injection using dextranomer/hyaluronic acid for treating VUR in pediatric patients.
- To determine the success rate and complication profile of this minimally invasive procedure.
Summary:
- 58 children with VUR (grades II-V) underwent endoscopic subureteral injection of dextranomer/hyaluronic acid (Deflux).
- The study included 95 ureters, with reflux classified by grade.
- Follow-up involved micturitional cystography and ultrasound.
Impact:
- Endoscopic treatment achieved high remission rates: 66.31% after the first injection, 13.68% after the second, and 1.05% after the third.
- The procedure demonstrated significant advantages, including a high success rate, absence of postoperative complications, and reduced hospitalization.
- Endoscopic subureteral injection is indicated for all grades of VUR, offering a safe and effective treatment option.
Introduction:
Although vesicoureteral reflux (VUR) is a relatively common disease, in present there are different opinions regarding its approach by paediatric urologist, nephrologist and paediatrician. European Society for Paediatric Urology, European Association of Perinatal Medicine in collaboration with paediatric nephrologists developed--based on multicentric studies--a consensus approach for this disease. An efficient alternative is represented by endoscopic treatment.
Materials And Methods:
From January 2002 to December 2008 a number of 58 children, confirmed after mictional cistography with the diagnosis of VUR grade II - V, went endoscopic subureteral injection of dextranomer/ hyaluronic acid (Deflux). The reflux was unilateral in 21 cases and bilateral for the rest of 37. From 95 ureters, VUR was considered grade II - V in 15(15,79%), 45(47,37%), 28(29,47%) and 7(7,37%) cases. Follow-up and evaluation were based on mictional cistography and ultrasound examination.
Results And Conclusions:
Reflux remitted after the first, the second or the third injection in 63(66,31%), 13(13,68%) and 1(1,05%) of the ureters. These results confirm the fact that endoscopic subureteral injection of an adequate material confers semnificative advantages. High rate of success, absence of postoperative complications, reduced period of hospitalization sustain this kind of treatment that is indicated in all grades of reflux.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urinary Tract Calculi III: Medical Management
Urologic Endoscopic Procedure: Cystoscopic Examination
Imaging Studies VI: Voiding Cystourethrography and Cystography
Kidney Transplant II: Surgical Procedure
